You are here

Genmab

The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings

Yahoo/Benzinga

Sun, 07/14/19 - 04:09 pm

Seattle Genetics

Intuitive Surgical

Mirum Pharmaceuticals

Fulcrum Therapeutics

Genmab steps up for a $500M IPO haul, with its sights on a record-setting market cap

Endpoints

Wed, 07/10/19 - 10:49 am

J&J bags $150M option on Genmab's Darzalex successor

Fierce Biotech

Tue, 06/11/19 - 09:34 am

Multiple Myeloma

drug development

Genmab files for $500M IPO to fund multi-front cancer R&D push

Fierce Biotech

Wed, 05/29/19 - 10:02 am

antibody-drug conjugate

cervical cancer

MorphoSys Settles Patent Lawsuit with Janssen and Genmab

CP Wire

Fri, 02/1/19 - 09:44 am

MorphoSys Settles Patent Lawsuit with Janssen and Genmab

Fri, 02/1/19 - 09:43 am

patent lawsuits

MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab

CP Wire

Mon, 01/28/19 - 11:02 am

MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab

Mon, 01/28/19 - 10:10 am

Genmab's blockbuster Darzalex surpasses $2B in sales

BioCentury

Tue, 01/8/19 - 11:40 pm

Multiple Myeloma

Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial

BioSpace

Tue, 10/30/18 - 12:06 pm

clinical trials

Multiple Myeloma

Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more

Endpoints

Thu, 07/12/18 - 06:27 pm

cancer immunotherapy

Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors

CP Wire

Thu, 07/12/18 - 09:17 am

Seattle Genetics

colorectal cancer

non-small cell lung cancer

pancreatic cancer

head and neck cancer

cervical cancer

tisotumab vedotin

clinical trials

Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results

Xconomy

Tue, 05/29/18 - 11:36 am

clinical trials

Danish biotech Genmab hit by ending of trial using key cancer drug

Reuters

Mon, 05/28/18 - 01:35 pm

Genmab hits roadblock in non-Hodgkin lymphoma

Biopharma Dive

Sat, 05/26/18 - 09:20 am

non-Hodgkin's lymphoma

clinical trials

Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.

Fierce Pharma

Mon, 01/22/18 - 05:41 pm

chronic lymphocytic leukemia

Genmab and J&J 'love' partnership as some ponder takeover

Yahoo/Reuters

Thu, 11/30/17 - 09:42 am

Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort

Endpoints

Tue, 08/29/17 - 09:36 am

Seattle Genetics

antibody-drug conjugate

tisotumab vedotin

Genmab gains on promising early success for daratumumab PhIII in multiple myeloma, but questions linger

Endpoints

Fri, 08/25/17 - 09:49 am

Multiple Myeloma

clinical trials

Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years

Motley Fool

Sat, 08/5/17 - 09:43 am

specialty medicines

Pages